Mandate

Vinge advises Advania’s shareholders in connection with the divestment to funds managed by Goldman Sachs

Vinge has advised the IT-provider company Advania with the divestment of a majority of the shares to funds managed by Goldman Sachs alongside management, VIA Equity and other reinvesting shareholders.

Today headquartered in Stockholm, Advania is a leading full-service IT-provider with a presence in all Nordic countries, delivering mission-critical IT solutions to meet every need.  Advania employs around 1,400 individuals in 27 locations in Sweden, Iceland, Norway, Finland and Denmark. Advania today has a turnover more than SEK 5bn, having delivered more than 20% growth each of the last five years. 

Goldman Sachs is a global leader in private equity, with a strong track record of investing in the technology sector and in the Nordics. To partner with them is not only a stamp of approval of what we have achieved so far but also a promise to everyone here at Advania that the journey ahead will be full of excitement and new possibilities. Most important is that we can stay true to our core ambition: to be a real partner to all customers and a great workplace that keeps on attracting the best talent, says Mikael Noaksson, Advania’s group CEO.

Vinge’s team consisted of Peter Sundgren, Joacim Rydergård, Samra Baytar, Elsie Nassar, Nina Gransäter and Gustav Persson (M&A), Axel Jansson and Rebecka Målquist (Banking and Finance), Jolene Reimerson and Mathilda Persson (Commercial Agreements), Sara Strandberg (Employment), Karl-Hugo Engdahl (IT & GDPR), Sofia Bergenstråhle (Intellectual Property), Karolina Cohrs (Real Property), John Wahlbom (Competition law), Tove Lövgren Frisk (Compliance) and Jessica Öijer and Nathalie Hughes (VDR).

Related

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024

Vinge advises Triton in connection with the divestment of Norstat to Nalka Invest

Vinge advises Triton Smaller Mid-Cap Fund I (“Triton”) in connection with the divestment of Norstat, a leading data collector for market research, to Nalka Invest.
April 12, 2024